An achaete-scute homologue essential for neuroendocrine differentiation in the lung.

PubWeight™: 2.29‹?› | Rank: Top 2%

🔗 View Article (PMID 9126746)

Published in Nature on April 24, 1997

Authors

M Borges1, R I Linnoila, H J van de Velde, H Chen, B D Nelkin, M Mabry, S B Baylin, D W Ball

Author Affiliations

1: The Oncology Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.

Articles citing this

Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity. Genes Dev (2002) 3.22

Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol (2000) 3.13

Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm. J Biol (2004) 2.71

Notch signaling promotes airway mucous metaplasia and inhibits alveolar development. Development (2009) 2.10

Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc Natl Acad Sci U S A (2000) 2.02

Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell (2014) 1.84

The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumours: a comment on concepts and classification of mixed exocrine-endocrine neoplasms. Virchows Arch (2006) 1.82

Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Cancer Res (2009) 1.55

Notch signaling induces rapid degradation of achaete-scute homolog 1. Mol Cell Biol (2002) 1.51

Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy. Cancer Metastasis Rev (2010) 1.46

EVOPRINTER, a multigenomic comparative tool for rapid identification of functionally important DNA. Proc Natl Acad Sci U S A (2005) 1.38

PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am J Pathol (1999) 1.36

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo. Sci Transl Med (2015) 1.33

Neuroepithelial body microenvironment is a niche for a distinct subset of Clara-like precursors in the developing airways. Proc Natl Acad Sci U S A (2012) 1.31

Different assemblies of Notch receptors coordinate the distribution of the major bronchial Clara, ciliated and neuroendocrine cells. Development (2012) 1.29

RNA interference of achaete-scute homolog 1 in mouse prostate neuroendocrine cells reveals its gene targets and DNA binding sites. Proc Natl Acad Sci U S A (2004) 1.22

HES-1 repression of differentiation and proliferation in PC12 cells: role for the helix 3-helix 4 domain in transcription repression. Mol Cell Biol (2000) 1.21

Gfi/Pag-3/senseless zinc finger proteins: a unifying theme? Mol Cell Biol (2004) 1.19

ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers. Proc Natl Acad Sci U S A (2014) 1.17

The Drosophila basic helix-loop-helix protein DIMMED directly activates PHM, a gene encoding a neuropeptide-amidating enzyme. Mol Cell Biol (2007) 1.16

Molecular pathways and therapeutic targets in lung cancer. Oncotarget (2014) 1.16

BMP-2 decreases Mash1 stability by increasing Id1 expression. EMBO J (2004) 1.16

Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method. Cancer (2010) 1.15

A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype. Proc Natl Acad Sci U S A (2004) 1.15

Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway. Mol Biol Cell (2012) 1.12

Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes Dev (2015) 1.11

Stem cells in the lung. Methods Enzymol (2006) 1.10

Thyroid hormone receptor repression is linked to type I pneumocyte-associated respiratory distress syndrome. Nat Med (2011) 1.07

Histone demethylases and cancer. Adv Cancer Res (2009) 1.05

Selective tropism of Seneca Valley virus for variant subtype small cell lung cancer. J Natl Cancer Inst (2013) 1.02

MicroRNAs and lung cancers: from pathogenesis to clinical implications. Front Med (2012) 1.00

ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation. Oncogene (2013) 0.97

Guidance molecules in lung cancer. Cell Adh Migr (2010) 0.97

The growth factor independence-1 transcription factor: new functions and new insights. Crit Rev Oncol Hematol (2006) 0.97

Small cell lung cancer: will recent progress lead to improved outcomes? Clin Cancer Res (2015) 0.94

Targeted disruption of NeuroD, a proneural basic helix-loop-helix factor, impairs distal lung formation and neuroendocrine morphology in the neonatal lung. J Biol Chem (2008) 0.94

Mammalian Scratch: a neural-specific Snail family transcriptional repressor. Proc Natl Acad Sci U S A (2001) 0.93

NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas. Int J Cancer (2015) 0.92

The role of hypoxia and neurogenic genes (Mash-1 and Prox-1) in the developmental programming and maturation of pulmonary neuroendocrine cells in fetal mouse lung. Lab Invest (2009) 0.92

Expression of the active Notch1 decreases MTC tumor growth in vivo. J Surg Res (2011) 0.91

Loss of GFI1 impairs pulmonary neuroendorine cell proliferation, but the neuroendocrine phenotype has limited impact on post-naphthalene airway repair. Lab Invest (2007) 0.89

Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer. Am J Transl Res (2010) 0.85

Hyperplasia of pulmonary neuroepithelial bodies (NEB) in lungs of prolyl hydroxylase -1(PHD-1) deficient mice. Adv Exp Med Biol (2012) 0.84

ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs. Cell Rep (2016) 0.83

Multidirectional differentiation of Achaete-Scute homologue-1-defined progenitors in lung development and injury repair. Am J Respir Cell Mol Biol (2012) 0.82

Wnt and FGF mediated epithelial-mesenchymal crosstalk during lung development. Dev Dyn (2014) 0.82

YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer. Cancer Sci (2016) 0.82

Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas. Virchows Arch (2010) 0.82

Molecular characterization of the peripheral airway field of cancerization in lung adenocarcinoma. PLoS One (2015) 0.81

Achaete-scute homologue-1 tapers neuroendocrine cell differentiation in lungs after exposure to naphthalene. Toxicol Sci (2010) 0.81

NeuroD1 regulation of migration accompanies the differential sensitivity of neuroendocrine carcinomas to TrkB inhibition. Oncogenesis (2013) 0.80

Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2. Prostate (2012) 0.80

Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids. Cancer Gene Ther (2015) 0.80

Diversity of epithelial stem cell types in adult lung. Stem Cells Int (2015) 0.80

Human achaete-scute homolog-1 expression in neuroendocrine breast carcinoma. Virchows Arch (2012) 0.80

E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer. Biochem J (1999) 0.80

Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancer. Am J Surg (2010) 0.79

Identification of Achaete-scute complex-like 1 (ASCL1) target genes and evaluation of DKK1 and TPH1 expression in pancreatic endocrine tumours. BMC Cancer (2009) 0.79

Cellular and molecular biology of small cell lung cancer: an overview. Transl Lung Cancer Res (2016) 0.79

DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma. BMC Res Notes (2012) 0.79

Neuroendocrine cancer-specific up-regulating mechanism of insulin-like growth factor binding protein-2 in small cell lung cancer. Am J Pathol (2009) 0.79

Developmental programs of lung epithelial progenitors: a balanced progenitor model. Wiley Interdiscip Rev Dev Biol (2014) 0.79

Proprotein convertase PACE4 is down-regulated by the basic helix-loop-helix transcription factor hASH-1 and MASH-1. Biochem J (2001) 0.78

Toppling high-grade pulmonary neuroendocrine tumors with a DLL3-targeted trojan horse. Mol Cell Oncol (2016) 0.77

Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle. Open Access J Urol (2010) 0.77

Systematic analysis of the achaete-scute complex-like gene signature in clinical cancer patients. Mol Clin Oncol (2016) 0.77

EZH2 promotes progression of small cell lung cancer by suppressing the TGF-β-Smad-ASCL1 pathway. Cell Discov (2015) 0.76

Achaete-scute complex homolog-1 promotes DNA repair in the lung carcinogenesis through matrix metalloproteinase-7 and O(6)-methylguanine-DNA methyltransferase. PLoS One (2012) 0.76

[Small cell lung cancer: pathology and molecular pathology]. Pathologe (2009) 0.75

Hyperplasia and hypertrophy of pulmonary neuroepithelial bodies, presumed airway hypoxia sensors, in hypoxia-inducible factor prolyl hydroxylase-deficient mice. Hypoxia (Auckl) (2016) 0.75

Co-expression of Achaete-Scute Homologue-1 and Calcitonin Gene-Related Peptide during NNK-Induced Pulmonary Neuroendocrine Hyperplasia and Carcinogenesis in Hamsters. J Cancer (2016) 0.75

Mash1 efficiently reprograms rat astrocytes into neurons. Neural Regen Res (2014) 0.75

Expression of Notch 1 receptor associated with tumor aggressiveness in papillary thyroid carcinoma. Onco Targets Ther (2016) 0.75

Staurosporine and extracellular matrix proteins mediate the conversion of small cell lung carcinoma cells into a neuron-like phenotype. PLoS One (2014) 0.75

Apc deficiency alters pulmonary epithelial cell fate and inhibits Nkx2.1 via triggering TGF-beta signaling. Dev Biol (2013) 0.75

Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol (2017) 0.75

Small-cell lung cancer: what we know, what we need to know and the path forward. Nat Rev Cancer (2017) 0.75

Articles by these authors

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A (1996) 29.54

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (1996) 16.92

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature (2004) 16.76

CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A (1999) 13.02

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med (2000) 12.34

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care (2001) 9.76

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A (1998) 9.66

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet (1999) 9.53

5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med (1995) 9.10

A gene hypermethylation profile of human cancer. Cancer Res (2001) 8.93

Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet (1994) 8.34

Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res (1997) 7.95

Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res (1995) 7.42

Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci U S A (2005) 7.12

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst (2000) 6.38

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res (1999) 6.10

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A (1995) 5.92

Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature (1995) 5.91

Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? J Virol (2005) 5.78

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell (1998) 5.78

DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet (2000) 5.72

Genetic diversity and disease control in rice. Nature (2000) 5.34

E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res (1995) 5.11

Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell (2000) 5.08

Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell (1999) 5.07

Crystal structure of a TFIIB-TBP-TATA-element ternary complex. Nature (1995) 4.93

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol (2000) 4.75

Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci U S A (2006) 4.49

Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res (1998) 4.39

A transcriptional switch mediated by cofactor methylation. Science (2001) 4.32

Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A (1998) 3.80

Superconductivity at 43 K in SmFeAsO1-xFx. Nature (2008) 3.80

The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia (2008) 3.69

Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res (2000) 3.65

Generation of coated intermediates of clathrin-mediated endocytosis on protein-free liposomes. Cell (1998) 3.62

Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam. Virology (2006) 3.59

Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol (1991) 3.59

Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome. Cell (2000) 3.59

Synaptic vesicle endocytosis impaired by disruption of dynamin-SH3 domain interactions. Science (1997) 3.59

Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J Virol (2005) 3.51

Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res (1996) 3.50

Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res (1999) 3.48

Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J Exp Med (1997) 3.48

Prevalence and genetic diversity of coronaviruses in bats from China. J Virol (2006) 3.37

A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell (1999) 3.36

NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem Suppl (1996) 3.24

Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem (2001) 3.23

Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res (1994) 3.18

Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res (1997) 3.17

Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res (1999) 3.15

Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature (1997) 3.14

The genesis and evolution of H9N2 influenza viruses in poultry from southern China, 2000 to 2005. J Virol (2007) 3.12

Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res (1997) 3.09

CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling. Oncogene (2011) 3.08

Plasma urate and risk of Parkinson's disease. Am J Epidemiol (2007) 3.06

Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res (2000) 2.99

Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem (2000) 2.97

CpG methylation is maintained in human cancer cells lacking DNMT1. Nature (2000) 2.94

The ovalbumin gene is associated with the nuclear matrix of chicken oviduct cells. Cell (1982) 2.86

Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res (2001) 2.79

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res (2000) 2.79

The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem (1996) 2.75

p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene (1992) 2.64

Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med (1998) 2.64

The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol (1991) 2.63

Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res (1999) 2.62

The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev (1998) 2.58

Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding. Nature (2000) 2.57

Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood (1999) 2.57

Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst (1997) 2.52

Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol Endocrinol (1997) 2.51

Phenotypes Associated with SHOX Deficiency. J Clin Endocrinol Metab (2001) 2.51

DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet (2001) 2.50

Evolution and molecular epidemiology of H9N2 influenza A viruses from quail in southern China, 2000 to 2005. J Virol (2006) 2.47

p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med (1995) 2.47

Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179). J Biol Chem (2001) 2.42

Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene (2011) 2.36

A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol (2000) 2.35

Methylation-specific PCR simplifies imprinting analysis. Nat Genet (1997) 2.33

Infection of immunocompromised patients by avian H9N2 influenza A virus. J Infect (2011) 2.29

DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. Gut (2008) 2.29

Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem (1995) 2.28

Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem (1997) 2.27

Establishment of influenza A virus (H6N1) in minor poultry species in southern China. J Virol (2007) 2.26

De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol Cell Biol (1996) 2.26

DNA methylation, chromatin inheritance, and cancer. Oncogene (2001) 2.26

Colloid cyst of the third ventricle: imaging-pathologic correlation. AJNR Am J Neuroradiol (2000) 2.23

Two-dimensional imaging through diffusing media using 150-fs gated electronic holography techniques. Opt Lett (1991) 2.21

A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat Neurosci (2000) 2.20

Nitrogen fixation ability of exopolysaccharide synthesis mutants of Rhizobium sp. strain NGR234 and Rhizobium trifolii is restored by the addition of homologous exopolysaccharides. J Bacteriol (1987) 2.17

Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res (1999) 2.17

Evolutionary insights into the ecology of coronaviruses. J Virol (2007) 2.16

Crystal structure of a human TATA box-binding protein/TATA element complex. Proc Natl Acad Sci U S A (1996) 2.15

The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. Proc Natl Acad Sci U S A (1988) 2.14

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer (2008) 2.13